Recently, the CORONA and GISSI-HF trials showed that an elevated PTX3 concentration was associated with age and advanced NYHA class, and this marker independently predicted fatal outcomes in CHF patients over a 3-month period [14]. The gene discussed is PTX3; the disease is hydrops fetalis.